Dataset opportunity
Filab — Industrial Operations Dataset Opportunity
Moderate industrial operations dataset held by Filab, usable for Industrial Monitoring and Forecasting.
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
44%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI-enabled Medical Devices market size was estimated at $13.67 billion in 2024, projected to grow at a 38.5% CAGR from 2025 to 2033 (source: Grand View Research). [4]
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Industrial Operations Dataset
Modality
Time Series
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
Industrial AI integrators
Filab possesses a valuable collection of Time Series data derived from the analytical testing of medical devices. This `industrial_data` includes outputs from GC-MS, ICP, and SEM analyses, providing a detailed, time-stamped chemical and physical characterization of materials, which is highly suitable for Industrial Monitoring AI applications like predictive quality control and manufacturing anomaly detection, all within a `regulatory` compliant framework (ISO 17025).
The global market for AI in medical devices is substantial and rapidly expanding, projected to grow from $13.67 billion in 2024 to $255.76 billion by 2033, driven by a 38.5% CAGR. [4] Despite access complexities, such as service contracts governing data ownership and strict confidentiality requirements, the rarity and high potential of this data to optimize manufacturing processes and ensure quality make negotiating access, possibly via robust anonymization, a worthwhile endeavor for AI buyers looking to capitalize on this significant market growth. ⚠ Diligence (valuable data, access to negotiate): Data ownership is typically governed by service contracts with medical device manufacturers.; Raw analytical data (GC-MS, ICP, SEM) is likely stored but not systematically exploited across clients.; Strict confidentiality and ISO 17025 compliance requirements may restrict data sharing without anonymization. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence proves Filab owns a proprietary time-series dataset detailing the chemical degradation and impurities of medical devices. This data is highly sought after by Industrial AI integrators to build and validate industrial monitoring and predictive quality control models. In a market for AI-enabled medical devices projected to grow at a 38.5% CAGR, this dataset is a critical asset for ensuring product safety, performance, and regulatory compliance.
See dimension details ↓- Dataset Specificity78
dominant 'industrial_data', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Industrial Monitoring
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand80
Buyer demand is high, driven by the exceptional growth in the AI-enabled medical devices market, which shows a **38.5% CAGR**, indicating a strong appetite for specialized data that powers industrial monitoring and quality optimization. [4]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength53
2 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ review — Filab's core business is selling analytical services and R&D support, which is a form of selling intelligence, making it a bad fit as it's already on the market. Issues: The company's core business is providing analytical services, expertise, and R&D support, which is explicitly defined as a 'BAD target' (selling intelligence/in; The data generated is the primary deliverable for which clients pay, not a 'dormant' or 'exhaust' by-product of a separate operational business. [9, 15]; The
- Deep Qualification90
⚠ needs review — Filab is a service-based contract laboratory whose business model is to perform analyses for clients; the resulting data is owned by the customer, making it unavailable for third-party licensing. [data is owned by the company's customers; licensing restricted]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This time-series data, derived from high-resolution mass spectrometry, tracks the degradation and impurities of polymer medical devices, providing the ground truth for predictive quality control models.
Regulatory records
This evidence confirms the data is generated in accordance with ISO 10993 standards for chemical characterization, a critical requirement for any AI solution intended for the regulated medical device industry.
Deal room
Deal Room — Filab — Industrial Operations Dataset Opportunity
Industrial Operations Dataset (Time Series, healthcare). Best AI use-case: Industrial Monitoring. Target buyers: Industrial AI integrators. Market: Global AI-enabled Medical Devices market size was estimated at $13.67 billion in 2024, projected to grow at a 38.5% CAGR from 2025 to 2033 (source: Grand View Research). [4]. Rarity: High (proprietary); accessibility: Restricted. Key risk: Mixed ownership — licensing rights to clarify. Recommended deal structure: Acquire. Investment score 47.5/100.
Buyer persona
Industrial AI integrators
The type of company or team most likely to buy or use this dataset — the target on the demand side.Market
Global AI-enabled Medical Devices market size was estimated at $13.67 billion in 2024, projected to grow at a 38.5% CAGR from 2025 to 2033 (source: Grand View Research). [4]
A rough read on demand and price band for this data, from market signals ($ = niche, $$$ = high AI-buyer demand).Risk
Mixed ownership — licensing rights to clarify
The main legal and compliance constraints on using or transferring this data — PII/GDPR, licensing rights, regulatory limits.Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Coverage
Scanned sources
Deliverable
Premium dataset report
Filab Inspection Reports — a Moderate inspection reports dataset (Document modality) in the industrial domain. Primary AI use-case: Document Intelligence. Market signal: Global Intelligent Document Processing market = $2.3B in 2024, CAGR 24.7% (source: Global Market Insights). Investment score 65.0/100 (confidence 0.49). Recommended action: Partnership (group-level).